72
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Predictors of duloxetine adherence and persistence in patients with fibromyalgia

, , &
Pages 193-201 | Published online: 22 Jun 2012

References

  • WrightCLMistSDRossRLJonesKDDuloxetine for the treatment of fibromyalgiaExpert Rev Clin Immunol20106574575620828282
  • Schmidt-WilckeTClauwDJPharmacotherapy in f ibromyalgia (FM) – implications for the underlying pathophysiologyPharmacol Ther2010127328329420388527
  • BergerADukesEMartinSEdelsbergJOsterGCharacteristics and healthcare costs of patients with fibromyalgia syndromeInt J Clin Pract20076191498150817655684
  • NeumannLBuskilaDEpidemiology of fibromyalgiaCurr Pain Headache Rep20037536236812946289
  • NavarroRPContemporary management strategies for fibromyalgiaAm J Manag Care200915Suppl 7S197S21819601687
  • AnnemansLLe LayKTaiebCSocietal and patient burden of fibromyalgia syndromePharmacoeconomics200927754755919663526
  • StaudRVierckCJCannonRLMauderliAPPriceDDAbnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndromePain2001911–216517511240089
  • BasbaumAIFieldsHLEndogenous pain control systems: brainstem spinal pathways and endorphin circuitryAnnu Rev Neurosci198473093386143527
  • BannisterKBeeLADickensonAHPreclinical and early clinical investigations related to monoaminergic pain modulationNeurotherapeutics20096470371219789074
  • BellinghamGAPengPWDuloxetine: a review of its pharmacology and use in chronic pain managementReg Anesth Pain Med201035329430320921842
  • LegangneuxEMoraJJSpreux-VaroquauxOCerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H] imipramine reuptake in the primary fibromyalgia syndromeRheumatology (Oxford)200140329029611285376
  • RussellIJVaeroyHJavorsMNybergFCerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritisArthritis Rheum19923555505561374252
  • ArnoldLMRosenAPritchettYLA randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorderPain20051191–351516298061
  • ArnoldLMLuYCroffordLJA double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorderArthritis Rheum20045092974298415457467
  • RussellIJMeasePJSmithTREfficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trialPain2008136343244418395345
  • ChappellASBradleyLAWiltseCDetkeMJD’SouzaDNSpaethMA six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgiaInt J Gen Med200919110220428412
  • KleinmanNLSanchezRJLynchWDCappelleriJCBerenIAJoshiAVHealth outcomes and costs among employees with fibromyalgia treated with pregabalin vs standard of carePain Pract201111654055121392253
  • ZhaoYSunPWatsonPMitchellBSwindleRComparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgiaPain Pract201111320421620807351
  • ZhaoYChenSYWuNFraserKABoulangerLMedication adherence and healthcare costs among fibromyalgia patients treated with duloxetinePain Pract201111438139121199311
  • WuNChenSBoulangerLRaoPZhaoYAverage daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetineCurr Med Res Opin20112761131113921456939
  • CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
  • American Psychiatric AssociationPractice Guideline for Treatment of Patients with Major Depressive Disorder2nd edWashingtonAmerican Psychiatric Association Press2000
  • FitzcharlesMASte-MariePAGamsaAWareMAShirYOpioid use, misuse, and abuse in patients labeled as fibromyalgiaAm J Med20111241095596021962316
  • SerraEDuloxetine and pregabalin: safe and effective for the long-term treatment of fibromyalgia?Nat Clin Pract Neurol2008459459518852724
  • MeasePFibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatmentJ Rheumatol Suppl20057562116078356
  • YunusMBMasiATAldagJCShort term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trialJ Rheumatol19891645275322664173
  • SolitarBMFibromyalgia: knowns, unknowns, and current treatmentBull NYU Hosp Jt Dis201068315716120969544